Profile
Full Name
Krystal Biotech, Inc.Ticker Symbol
KRYSExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
September 20, 2017Indexes
Not includedWebsite
http://www.krystalbio.comEmployees
275Key Details
Price
$168.06(-0.63%)
Market cap
$4.86B(Mid cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$290.51M(+473.02% YoY)
Annual EPS
$3.00(+669.23% YoY)
PE ratio
56.21
Next earnings date
May 6, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Krystal Biotech doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 5, 25 Jefferies
BuyFeb 28, 25 HC Wainwright & Co.
BuyFeb 20, 25 Citigroup
NeutralFeb 20, 25 Chardan Capital
BuyFeb 20, 25 Cantor Fitzgerald
OverweightFeb 19, 25 HC Wainwright & Co.
BuyDec 18, 24 HC Wainwright & Co.
BuyDec 18, 24 Chardan Capital
BuyDec 13, 24 HC Wainwright & Co.
BuyDec 12, 24 Chardan Capital
BuyInstitutional Ownership
- What is the ticker symbol for Krystal Biotech?
- Does Krystal Biotech pay dividends?
- What sector is Krystal Biotech in?
- What industry is Krystal Biotech in?
- What country is Krystal Biotech based in?
- When did Krystal Biotech go public?
- Is Krystal Biotech in the S&P 500?
- Is Krystal Biotech in the NASDAQ 100?
- Is Krystal Biotech in the Dow Jones?
- When was Krystal Biotech's last earnings report?
- When does Krystal Biotech report earnings?
- Should I buy Krystal Biotech stock now?
What is the ticker symbol for Krystal Biotech?
The ticker symbol for Krystal Biotech is NASDAQ:KRYS
Does Krystal Biotech pay dividends?
No, Krystal Biotech does not pay dividends
What sector is Krystal Biotech in?
Krystal Biotech is in the Healthcare sector
What industry is Krystal Biotech in?
Krystal Biotech is in the Biotechnology industry
What country is Krystal Biotech based in?
Krystal Biotech is headquartered in United States
When did Krystal Biotech go public?
Krystal Biotech's initial public offering (IPO) was on September 20, 2017
Is Krystal Biotech in the S&P 500?
No, Krystal Biotech is not included in the S&P 500 index
Is Krystal Biotech in the NASDAQ 100?
No, Krystal Biotech is not included in the NASDAQ 100 index
Is Krystal Biotech in the Dow Jones?
No, Krystal Biotech is not included in the Dow Jones index
When was Krystal Biotech's last earnings report?
Krystal Biotech's most recent earnings report was on Feb 19, 2025
When does Krystal Biotech report earnings?
The next expected earnings date for Krystal Biotech is May 6, 2025
Should I buy Krystal Biotech stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions